Concomitant use of XANAX with solid CYP3A inhibitors includes a profound impact on the clearance of alprazolam, leading to amplified concentrations of alprazolam and improved hazard of adverse reactions [see Clinical Pharmacology (twelve.three)]. Prevention or administrationTry to remember, continue to keep this and all other medicines out of the a